NICOPASS

This brand name is authorized in Estonia, France, Poland, Tunisia.

Active ingredients

The drug NICOPASS contains one active pharmaceutical ingredient (API):

1
UNII 6M3C89ZY6R - NICOTINE
 

Nicotine, the primary alkaloid in tobacco products and a naturally occurring autonomous substance, is a nicotine receptor agonist in the peripheral and central nervous systems and has pronounced CNS and cardiovascular effects.
 
Read more about Nicotine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N07BA01 Nicotine N Nervous system → N07 Other nervous system drugs → N07B Drugs used in addictive disorders → N07BA Drugs used in nicotine dependence
Discover more medicines within N07BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1186107, 1186118, 1186129, 1186130, 1186141, 1186152, 1186163, 1186174, 1186185, 1186231, 1186242, 1186253, 1186264, 1186275, 1186286, 1186297, 1186309, 1186310
FR Base de données publique des médicaments 63563115, 67185182, 67523118, 67666657, 68852892
PL Rejestru Produktów Leczniczych 100160752, 100238767
TN Direction de la Pharmacie et du Médicament 6063313, 6063314

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈